<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
ARQT
Arcutis Biotherapeutics
$
()


  • Arcutis announces new long-term data from study of roflumilast in AD

    6/10/2024 - 14:32pm
  • Ventyx Biosciences announces appointment of Moore as COO

    5/16/2024 - 08:08am
  • What You Missed On Wall Street On Wednesday

    5/15/2024 - 17:03pm
  • What You Missed On Wall Street This Morning

    5/15/2024 - 12:01pm
  • Arcutis Biotherapeutics price target raised by $1 at Mizuho, here's why

    5/15/2024 - 06:45am
  • Fly Intel: After-Hours Movers

    5/14/2024 - 18:03pm
  • Arcutis Biotherapeutics reports Q1 EPS (32c), consensus (73c)

    5/14/2024 - 16:03pm
  • Arcutis Biotherapeutics options imply 12.9% move in share price post-earnings

    5/14/2024 - 14:34pm
  • Arcutis Biotherapeutics announces the JCAD published outcomes of ZORYVE

    5/13/2024 - 08:22am
  • Arcutis Biotherapeutics appoints David Topper as CFO

    4/10/2024 - 08:04am
  • Sol-Gel Technologies collaboration partner first-to-file ANDA generic to Zoryve

    4/1/2024 - 07:18am
  • Arcutis Biotherapeutics appoints Todd Tucker as CHRO

    3/11/2024 - 08:11am
  • Arcutis presents late-breaking data from INTEGUMENT-PED Phase 3 trial

    3/10/2024 - 16:09pm
  • Arcutis Biotherapeutics 15.79M share Spot Secondary priced at $9.50

    2/29/2024 - 06:43am
  • Arcutis Biotherapeutics announces $150M common stock offering

    2/28/2024 - 16:10pm
dynamic_feed Breaking News